These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 32601558)
21. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease]. Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877 [No Abstract] [Full Text] [Related]
22. Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure. Galli A; Lombardi F Cardiol Res Pract; 2016; 2016():2579832. PubMed ID: 26989555 [TBL] [Abstract][Full Text] [Related]
23. Management of heart failure with preserved ejection fraction: a review. Nanayakkara S; Kaye DM Clin Ther; 2015 Oct; 37(10):2186-98. PubMed ID: 26385583 [TBL] [Abstract][Full Text] [Related]
24. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Gerson MC; Caldwell JH; Ananthasubramaniam K; Clements IP; Henzlova MJ; Amanullah A; Jacobson AF Circ Cardiovasc Imaging; 2011 Mar; 4(2):87-93. PubMed ID: 21193691 [TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of exercise training in heart failure are lost in male diabetic rats. Boudia D; Domergue V; Mateo P; Fazal L; Prud'homme M; Prigent H; Delcayre C; Cohen-Solal A; Garnier A; Ventura-Clapier R; Samuel JL J Appl Physiol (1985); 2017 Dec; 123(6):1579-1591. PubMed ID: 28883044 [TBL] [Abstract][Full Text] [Related]
26. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers of heart failure with normal ejection fraction: a systematic review. Cheng JM; Akkerhuis KM; Battes LC; van Vark LC; Hillege HL; Paulus WJ; Boersma E; Kardys I Eur J Heart Fail; 2013 Dec; 15(12):1350-62. PubMed ID: 23845797 [TBL] [Abstract][Full Text] [Related]
28. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction. Voors AA; Shah SJ; Bax JJ; Butler J; Gheorghiade M; Hernandez AF; Kitzman DW; McMurray JJV; Wirtz AB; Lanius V; van der Laan M; Solomon SD Eur J Heart Fail; 2018 Nov; 20(11):1601-1610. PubMed ID: 30225882 [TBL] [Abstract][Full Text] [Related]
29. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Lam CS Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570 [TBL] [Abstract][Full Text] [Related]
30. Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure. Cikes M; Solomon SD Eur Heart J; 2016 Jun; 37(21):1642-50. PubMed ID: 26417058 [TBL] [Abstract][Full Text] [Related]
32. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336 [TBL] [Abstract][Full Text] [Related]
34. Trends in prevalence and outcome of heart failure with preserved ejection fraction. Owan TE; Hodge DO; Herges RM; Jacobsen SJ; Roger VL; Redfield MM N Engl J Med; 2006 Jul; 355(3):251-9. PubMed ID: 16855265 [TBL] [Abstract][Full Text] [Related]
35. Effects of carvedilol therapy in patients with heart failure with preserved ejection fraction - Results from the Croatian heart failure (CRO-HF) registry. Domagoj M; Branka JZ; Jelena M; Davor M; Duska G Med Clin (Barc); 2019 Jan; 152(2):43-49. PubMed ID: 29678315 [TBL] [Abstract][Full Text] [Related]